GB9008108D0 - Cycloalkano(b)dihydroindoles and-indolesulphonamides substituted by heterocycles - Google Patents

Cycloalkano(b)dihydroindoles and-indolesulphonamides substituted by heterocycles

Info

Publication number
GB9008108D0
GB9008108D0 GB909008108A GB9008108A GB9008108D0 GB 9008108 D0 GB9008108 D0 GB 9008108D0 GB 909008108 A GB909008108 A GB 909008108A GB 9008108 A GB9008108 A GB 9008108A GB 9008108 D0 GB9008108 D0 GB 9008108D0
Authority
GB
United Kingdom
Prior art keywords
dihydroindoles
cycloalkano
heterocycles
indolesulphonamides
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB909008108A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Priority to GB909008108A priority Critical patent/GB9008108D0/en
Publication of GB9008108D0 publication Critical patent/GB9008108D0/en
Priority to DK91104943.5T priority patent/DK0451634T3/da
Priority to EP91104943A priority patent/EP0451634B1/en
Priority to ES91104943T priority patent/ES2062591T3/es
Priority to AT91104943T priority patent/ATE102618T1/de
Priority to DE69101330T priority patent/DE69101330T2/de
Priority to US07/679,710 priority patent/US5204374A/en
Priority to JP3097906A priority patent/JPH04234846A/ja
Priority to NZ237709A priority patent/NZ237709A/en
Priority to CA002039873A priority patent/CA2039873A1/en
Priority to IL9779591A priority patent/IL97795A/en
Priority to PT97280A priority patent/PT97280A/pt
Priority to IE118691A priority patent/IE64843B1/en
Priority to TW080102639A priority patent/TW221995B/zh
Priority to ZA912609A priority patent/ZA912609B/xx
Priority to KR1019910005656A priority patent/KR910018374A/ko
Priority to HU911140A priority patent/HU209645B/hu
Priority to AU74252/91A priority patent/AU632213B2/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GB909008108A 1990-04-10 1990-04-10 Cycloalkano(b)dihydroindoles and-indolesulphonamides substituted by heterocycles Pending GB9008108D0 (en)

Priority Applications (18)

Application Number Priority Date Filing Date Title
GB909008108A GB9008108D0 (en) 1990-04-10 1990-04-10 Cycloalkano(b)dihydroindoles and-indolesulphonamides substituted by heterocycles
DK91104943.5T DK0451634T3 (da) 1990-04-10 1991-03-28 Cycloalkano(b)dihydroindoler og -indolsulfonamidersubstitueret med heterocycliske ringe
EP91104943A EP0451634B1 (en) 1990-04-10 1991-03-28 Cycloalkano[b]dihydroindoles and -indolesulphonamides substituted by heterocycles
ES91104943T ES2062591T3 (es) 1990-04-10 1991-03-28 Cicloalcano (b) dihidroindoles e -indol sulfonamidas sustituidos por heterociclos.
AT91104943T ATE102618T1 (de) 1990-04-10 1991-03-28 Mit einem heterocyclischen ring substituierte cycloalkano(b>dihydroindole und indolsulfonamide.
DE69101330T DE69101330T2 (de) 1990-04-10 1991-03-28 Mit einem heterocyclischen Ring substituierte Cycloalkano[b]dihydroindole und -indolsulfonamide.
US07/679,710 US5204374A (en) 1990-04-10 1991-04-03 Cycloalkano(b)dihydroindoles and -indolesulphonamides substituted by heterocycles
JP3097906A JPH04234846A (ja) 1990-04-10 1991-04-04 複素環置換シクロアルカノ〔ｂ〕ジヒドロインドール類および−インドールスルホンアミド類
CA002039873A CA2039873A1 (en) 1990-04-10 1991-04-05 Cycloalkano(b)dihydroindoles and -indolesulphonamides substituted by heterocycles
NZ237709A NZ237709A (en) 1990-04-10 1991-04-05 Substituted cycloalkano-dihydroindoles, preparation and pharmaceutical compositions thereof
IL9779591A IL97795A (en) 1990-04-10 1991-04-08 Cilcoalkano [b] dihydroindoles and indolesulfonamides are converted by the heterocycles and their pharmaceutical preparations
PT97280A PT97280A (pt) 1990-04-10 1991-04-08 Processo para a preparacao de cicloalcano{b}di-hidroindole-sulfonamidas e cicloalcano {b}indole-sulfonamidas, substituidas por heterociclos
IE118691A IE64843B1 (en) 1990-04-10 1991-04-09 Cycloalkano[b]dihydroindoles and indolesulphonamides substituted by heterocycles
TW080102639A TW221995B (cg-RX-API-DMAC10.html) 1990-04-10 1991-04-09
ZA912609A ZA912609B (en) 1990-04-10 1991-04-09 Cycloalkano(b)dihydroindoles and-indolesulphonamides substituted by heterocycles
KR1019910005656A KR910018374A (ko) 1990-04-10 1991-04-09 헤테로사이클 치환된 시클로알카노[b] 디히드로인돌 및 -인돌술폰아미드
HU911140A HU209645B (en) 1990-04-10 1991-04-09 Process for producing heteroaryl-sulphonamido-carbazole derivatives
AU74252/91A AU632213B2 (en) 1990-04-10 1991-04-09 Cycloalkano (b) dihydroindoles and -indolesulphonamides substituted by heterocycles

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909008108A GB9008108D0 (en) 1990-04-10 1990-04-10 Cycloalkano(b)dihydroindoles and-indolesulphonamides substituted by heterocycles

Publications (1)

Publication Number Publication Date
GB9008108D0 true GB9008108D0 (en) 1990-06-06

Family

ID=10674203

Family Applications (1)

Application Number Title Priority Date Filing Date
GB909008108A Pending GB9008108D0 (en) 1990-04-10 1990-04-10 Cycloalkano(b)dihydroindoles and-indolesulphonamides substituted by heterocycles

Country Status (18)

Country Link
US (1) US5204374A (cg-RX-API-DMAC10.html)
EP (1) EP0451634B1 (cg-RX-API-DMAC10.html)
JP (1) JPH04234846A (cg-RX-API-DMAC10.html)
KR (1) KR910018374A (cg-RX-API-DMAC10.html)
AT (1) ATE102618T1 (cg-RX-API-DMAC10.html)
AU (1) AU632213B2 (cg-RX-API-DMAC10.html)
CA (1) CA2039873A1 (cg-RX-API-DMAC10.html)
DE (1) DE69101330T2 (cg-RX-API-DMAC10.html)
DK (1) DK0451634T3 (cg-RX-API-DMAC10.html)
ES (1) ES2062591T3 (cg-RX-API-DMAC10.html)
GB (1) GB9008108D0 (cg-RX-API-DMAC10.html)
HU (1) HU209645B (cg-RX-API-DMAC10.html)
IE (1) IE64843B1 (cg-RX-API-DMAC10.html)
IL (1) IL97795A (cg-RX-API-DMAC10.html)
NZ (1) NZ237709A (cg-RX-API-DMAC10.html)
PT (1) PT97280A (cg-RX-API-DMAC10.html)
TW (1) TW221995B (cg-RX-API-DMAC10.html)
ZA (1) ZA912609B (cg-RX-API-DMAC10.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5464746A (en) * 1991-12-17 1995-11-07 Abbott Laboratories Haptens, tracers, immunogens and antibodies for carbazole and dibenzofuran derivatives
JP3292731B2 (ja) * 1993-07-20 2002-06-17 アボツト・ラボラトリーズ カルバゾール及びジベンゾフラン誘導体用のハプテン、トレーサー、免疫原及び抗体
DE19506739A1 (de) * 1995-02-27 1996-08-29 Bayer Ag [3-Amino]-tetrahydrocarbazol-propansäureester
EP2423190A1 (en) * 2002-05-16 2012-02-29 Shionogi&Co., Ltd. Compounds Exhibiting PGD 2 Receptor Antagonism
WO2003097042A1 (en) * 2002-05-16 2003-11-27 Shionogi & Co., Ltd. Pgd2 receptor antagonist
EP1654228B1 (en) 2003-06-10 2008-10-22 Smithkline Beecham Corporation Tetrahydrocarbazole derivatives and their pharmaceutical use
ES2327416T3 (es) 2003-06-12 2009-10-29 Smithkline Beecham Corporation Derivados de tetraidrocarbazol y su uso farmaceutico.
AU2006262283B2 (en) * 2005-06-24 2011-10-13 Eli Lilly And Company Tetrahydrocarbazole derivatives useful as androgen receptor modulators (SARM)
US7601856B2 (en) 2006-07-27 2009-10-13 Wyeth Benzofurans as potassium ion channel modulators
US7662831B2 (en) 2006-07-27 2010-02-16 Wyeth Llc Tetracyclic indoles as potassium channel modulators
UA98777C2 (en) * 2006-11-20 2012-06-25 Эли Лилли Энд Компани Tetrahydrocyclopenta[b]indole compounds as androgen receptor modulators
CN101434571B (zh) * 2007-11-13 2012-05-30 杭州容立医药科技有限公司 环烷并[1,2-b]吲哚磺酰胺、其异构体或其盐的合成方法
EA019713B1 (ru) * 2008-05-16 2014-05-30 Эли Лилли Энд Компани ТЕТРАГИДРОЦИКЛОПЕНТА[b]ИНДОЛЬНЫЕ МОДУЛЯТОРЫ РЕЦЕПТОРОВ АНДРОГЕНОВ
EP2300425A4 (en) * 2008-06-24 2012-03-21 Panmira Pharmaceuticals Llc PROSTAGLANDIN D2 RECEPTOR CYCLOALCANEÝBINDLUCK ANTAGONISTS

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3946021A (en) * 1970-07-23 1976-03-23 Richardson-Merrell Inc. Bis-basic ketones of carbazole
US3975398A (en) * 1973-08-01 1976-08-17 Boehringer Mannheim G.M.B.H. 9-Substituted 3-aminocarbazole compounds
US4464379A (en) * 1981-06-01 1984-08-07 A. Nattermann & Cie Gmbh Indol acetic acid derivatives and anti-inflamatory and related uses thereof
DE3514696A1 (de) * 1985-04-24 1986-11-06 Bayer Ag, 5090 Leverkusen N-indolylethyl-sulfonsaeureamide, verfahren zu ihrer herstellung und ihre verwendung
DE3631824A1 (de) * 1986-02-21 1988-03-31 Bayer Ag Cycloalkano(1.2-b)indol-sulfonamide
US4940719A (en) * 1986-03-27 1990-07-10 Merck Frosst Canada, Inc. Tetrahydrocarbazole esters, pharmaceutical compositions and use
DE3613623A1 (de) * 1986-04-23 1987-10-29 Bayer Ag N-dihydroindolylethyl-sulfonamide

Also Published As

Publication number Publication date
PT97280A (pt) 1992-01-31
DE69101330D1 (de) 1994-04-14
IE64843B1 (en) 1995-09-06
EP0451634A3 (en) 1992-01-02
ATE102618T1 (de) 1994-03-15
DE69101330T2 (de) 1994-06-16
DK0451634T3 (da) 1994-05-02
ES2062591T3 (es) 1994-12-16
TW221995B (cg-RX-API-DMAC10.html) 1994-04-01
IL97795A0 (en) 1992-06-21
JPH04234846A (ja) 1992-08-24
CA2039873A1 (en) 1991-10-11
EP0451634B1 (en) 1994-03-09
EP0451634A2 (en) 1991-10-16
AU632213B2 (en) 1992-12-17
IL97795A (en) 1995-08-31
NZ237709A (en) 1992-10-28
IE911186A1 (en) 1991-10-23
AU7425291A (en) 1991-10-17
US5204374A (en) 1993-04-20
HUT57205A (en) 1991-11-28
HU209645B (en) 1994-09-28
KR910018374A (ko) 1991-11-30
HU911140D0 (en) 1991-10-28
ZA912609B (en) 1992-01-29

Similar Documents

Publication Publication Date Title
AU5799294A (en) Isoxazole-4-carboxamides and hydroxy-alkylidenecyanoacetamides, pharmaceuticals containing these compounds and their use
TW221995B (cg-RX-API-DMAC10.html)
CA2148928A1 (en) Pharmacologically active pyridine derivatives and processes for the preparation thereof
AU1834988A (en) Hexa-cyclic compound
MY129973A (en) Sulphonylbenzyl-substituted pyridones.
GB9027055D0 (en) Organic compounds
AU7993694A (en) Novel pyrazine carboxamide derivatives, their production and their use in medicaments
HU9303675D0 (en) Substituted 4-phenyl-pyridone and 4-phenyl-2-alkoxy-pyridine derivatives
WO1993000094A3 (en) Use of tetrahydrobenzazepine derivatives for the treatment of portal hypertension and migraine
GR3015836T3 (en) Sulphonylbenzyl substituted benzo- and pyridopyridones.
AU646439B2 (en) Novel retinoids
AU2861389A (en) Disubstituted pyridines
GR3031149T3 (en) Process for the manufacture of (s)-3-amino-1-substituted-pyrrolidines.
TW282468B (cg-RX-API-DMAC10.html)
HU9301870D0 (en) Cyclohexane derivatives holding imidazolyle substitutent
IL89401A0 (en) Medicaments containing 1,4-dihydropyridine derivatives for the treatment of alcohol addiction
MX9409573A (es) 1,4-dihidropiridinas substituidas con fenilo, procedimiento para su fabricacion y medicamentos que las contienen.
UA32057A (uk) Спосіб лікування кератоувеїтів різної етіології
MY103844A (en) New uses of 4-(3-phosphono-2-propenyl)-2-piperazine- carboxylic acid.